Company intelligence / Profile preview

Regenovo

Hangzhou, Zhejiang, China
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

Regenovo, formally known as Hangzhou Jienuofei Biotechnology, is a China-based biomedical 3D printing company focused on integrated solutions spanning bioprinters, biomaterials, software, imaging, and automated bio-manufacturing systems. The company serves research and translational medicine use cases in regenerative medicine, tissue engineering, drug discovery, and personalized healthcare rather than operating like a traditional therapeutics developer. Its offerings include bioprinting hardware, bio-inks and related materials, imaging and analysis systems, and manufacturing solutions for cells and tissue constructs. Regenovo appears to be an active private company headquartered in Hangzhou, Zhejiang, with commercialized products and services for laboratories, hospitals, and research institutions.

Therapeutic areas
Other
Modalities
DeviceBiologicCell therapyHydrogel-based drug delivery therapy
Industry
Non-Drug Biotech
02

Partnerships

Sichuan UniversitySouth China University of TechnologyPeking UniversityTsinghua UniversityZhejiang UniversityShanghai Jiao Tong UniversityHarbin Institute of TechnologyGuangxi Medical UniversityNational Taiwan UniversityCity University of Hong KongMacau University of Science and TechnologyWest China Hospital of Sichuan UniversitySir Run Run Shaw Hospital, Zhejiang University School of Medicine

Beyond the preview

Go deeper on Regenovo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenovo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call